Growth Opportunities and Trends in the Chronic Venous Occlusions Treatment Market: Key Insights for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the chronic venous occlusions treatment market right now?
In recent times, there has been a robust expansion in the market size for the treatment of chronic venous occlusions. Its growth projection is from $6.7 billion in 2024 to $7.19 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The growth experienced in the historical period can be linked to increased investment in innovative treatments, a surge in the prevalence of venous disorders, enhanced awareness and diagnostic improvements, clinical trials and research initiatives, and improvements in patient outcomes and quality of life.
How fast Is the chronic venous occlusions treatment market expected to grow, and what’s its future value?
The market for chronic venous occlusions treatment is anticipated to witness substantial expansion in the near future, escalating to a value of $9.32 billion by 2029 with a compound annual growth rate (CAGR) of 6.7%. The projected upliftment is owing to the heightened awareness surrounding venous disorders, surge in preference for minimally invasive treatments, changes in population age structure, development in endovascular therapies, and a patient-oriented approach to care. The main trends expected to be seen in the upcoming duration include the progression in minimally invasive techniques, advancements in interventional radiology technology, emphasis on endovascular therapies, escalating incidence of venous disorders, and an increase in the aged demographic.
Get your chronic venous occlusions treatment market report here!
What are the leading drivers of growth in the chronic venous occlusions treatment market?
The mounting prevalence of obesity is anticipated to boost the chronic venous occlusion treatment market. Described as a surplus buildup of body fat, reflected in a body mass index (BMI) of 30 or above, obesity can be mitigated with chronic venous occlusion treatment. This treatment method can lessen obesity-related symptoms like edema and skin changes by enhancing blood circulation and lowering inflammation, thus aiding in superior obesity management. For example, data from the World Heart Federation, a Swiss global cardiovascular community, shows that roughly 2.3 billion adults and children globally were obese or overweight in March 2023. Projections indicate that if the current obesity trend continues, around 2.7 billion people will be living with obesity by 2025. Hence, the rising obesity rates are stimulating the growth of the chronic venous occlusion treatment market.
Growth Catalyst for Chronic Venous Occlusions Treatment Market: The Surge in Adoption of Minimally Invasive Procedures
What are the key segments defining the chronic venous occlusions treatment market?
The chronic venous occlusions treatment market covered in this report is segmented –
1) By Product: Devices, Drugs
2) By Application: Varicose Veins, Venous Stasis Ulcers, Edema, Deep Vein Thrombosis, Other Applications
3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Trauma centers, Other End-Users
Subsegments:
1) By Devices: Venous Stents, Catheters, Endovenous Laser Therapy (EVLT) Devices, Angioplasty Balloons, Other Interventional Devices
2) By Drugs: Anticoagulants, Thrombolytics, Anti-inflammatory Medications, Pain Management Drugs, Other Pharmacological Treatments
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13286&type=smp
Who are the key players steering the development of the chronic venous occlusions treatment market?
Major companies operating in the chronic venous occlusions treatment market report are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA
What emerging trends are influencing the growth of the chronic venous occlusions treatment market?
Leading firms in the chronic venous occlusion treatment market are concentrating on creating new solutions like implantable medical devices, used to treat symptomatic venous outflow blockages in chronic venous insufficiency patients. An implantable medical device is a surgically inserted item, intended to stay within the body for an extended time to help diagnose, cure, or monitor health conditions. For instance, in June 2024, Koninklijke Philips N.V. (Philips), a technology company based in the Netherlands, introduced the Duo Venous Stent System, an implantable medical gadget. The Duo Venous Stent System from Koninklijke Philips N.V. incorporates a dual-layer design that boost flexibility and radial endurance for optimum vein support. Its sophisticated coating enhances biocompatibility and reduces the risk of thrombosis, while its precise delivery system guarantees exact placement, even under challenging anatomical circumstances.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13286
Which regions are most influential in expanding the chronic venous occlusions treatment market?
North America was the largest region in the chronic venous occlusions treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Condensed Whey Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/condensed-whey-global-market-report
Industrial Glucose Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/industrial-glucose-global-market-report
Vegan Protein Powder Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vegan-protein-powder-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
